Teva declines to comment on report it to make offer for Mylan

TEL AVIV, April 21 (Reuters) - Shares in generic drugmakers Teva Pharmaceutical Industries and Mylan jumped in pre-market trade in New York on a report from Bloomberg that Teva could make a public unsolicited offer for Mylan as soon as Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.